PostProcess Technologies’ Leading Resin Removal Detergent Officially Recognized as Biocompatible
Integral Component of Proven Automated Post-Printing Solution Achieves New Standard
for Use in Medical and Dental Fields
BUFFALO, NY, USA – August 5, 2021 – PostProcess Technologies Inc., the first and only trusted provider of automated and intelligent post-printing solutions for industrial 3D printing, has announced compliance with ISO standard 10993 for evaluation of biocompatibility of its popular resin removal detergent PLM-403-SUB, as validated by Toxikon Corporation. This detergent serves as an integral part of the company’s comprehensive automated resin removal solution.
On account of the detergent’s demonstration of compliance with requirements for biocompatibility, additive manufacturing users looking to maintain or incorporate fully biocompatible processes can seamlessly incorporate PostProcess’s leading resin removal solution into their workflow. Particularly, this will be an impactful new industry standard of post-printing for those in the dental and medical fields.
The proven detergent plays a significant role in PostProcess’s patented Submersed Vortex Cavitation (SVC) technology, which utilizes established software intelligence to ensure that 3D printed parts are uniformly, consistently, and reliably exposed to detergent as they undergo post-printing for precision finished parts. This technology is the definitive industry solution for a safer, more efficient post-printing process that promotes sustainability, even as production volumes scale.
Speaking to the new compliance achievement, PostProcess Technologies’ Lead Chemist, Matthew Noble, Ph.D., said, “We’ve always made seamless integration and dependability of our solutions a priority. With this compliance of biocompatibility, additive users can enjoy the efficiencies of automated resin removal as the new industry standard, and rest assured that their workflows and final products will meet necessary biocompatibility standards in a manner more sustainable than current market alternatives.”